Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer

被引:59
|
作者
Porta, M
Malats, N
Guarner, L
Carrato, A
Rifà, J
Salas, A
Corominas, JM
Andreu, M
Real, FX
机构
[1] Univ Autonoma Barcelona, Inst Municipal Invest Med, E-08003 Barcelona, Spain
[2] Hosp Gen Valle Hebron, Dept Gastroenterol, Barcelona, Spain
[3] Hosp Gen Elche, Dept Oncol, Alicante, Spain
[4] Hosp Son Dureta, Dept Oncol, Mallorca, Spain
[5] Hosp Mutua Terrassa, Dept Pathol, Barcelona, Spain
[6] Univ Autonoma Barcelona, Hosp Mar, Dept Pathol, E-08003 Barcelona, Spain
[7] Univ Autonoma Barcelona, Hosp Mar, Dept Gastroenterol, E-08003 Barcelona, Spain
关键词
D O I
10.1136/jech.53.11.702
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Study objective-To analyse the relation between coffee consumption and mutations in the K-ras gene in exocrine pancreatic cancer. Design-Case-case study. Consumption of coffee among cases with the activating mutation in the K-ras gene was compared with that of cases without the mutation. Setting and patients-All cases of pancreatic cancer newly diagnosed at five hospitals in Spain during three years were included in the PANKRAS II Study (n=185, of whom 121 whose tissue was available for molecular analysis are the object of the present report). Over 88% were personally interviewed in hospital. DNA was amplified from paraffin wax embedded tissues, and mutations in codon 12 of K-ras were detected by the artificial RFLP technique. Main results-Mutations were found in tumours from 94 of 121 patients (77.7%). Mutations were more common among regular coffee drinkers than among nonregular coffee drinkers (82.0% v 55.6%, p=0.018, n=107). The odds ratio adjusted by age, sex, smoking and alcohol drinking was 5.41 (95% CI 1.64, 17.78). The weekly intake of coffee was significantly higher among patients with a mutated tumour (mean of 14.5 cups/week v 8.8 among patients with a wild type tumour, p<0.05). With respect to non-regular coffee drinkers, the odds ratio of a mutated tumour adjusted by age, sex, smoking and alcohol drinking was 3.26 for drinkers of 2-7 cups/week, 5.77 for drinkers of 8-14 cups/week and 9.99 for drinkers of greater than or equal to 15 cups/week (p<0.01, test for trend). Conclusions-Pancreatic cancer cases without activating mutations in the K-ras gene had drank significantly less coffee than cases with a mutation, with a significant dose response relation: the less they drank, the less likely their tumours were to harbour a mutation. In exocrine pancreatic cancer the K-ras gene may be activated less often among non-regular coffee drinkers than among regular drinkers. Caffeine, other coffee compounds or other factors with which coffee drinking is associated may modulate K-ras activation.
引用
收藏
页码:702 / 709
页数:8
相关论文
共 50 条
  • [11] The relative influence of diet and serum concentrations of organochlorine compounds on K-ras mutations in exocrine pancreatic cancer
    Gasull, Magda
    Porta, Miquel
    Pumarega, Jose
    Vioque, Jesus
    Bosch de Basea, Magda
    Puigdomenech, Elisa
    Morales, Eva
    Grimalt, Joan O.
    Malats, Nuria
    CHEMOSPHERE, 2010, 79 (07) : 686 - 697
  • [12] K-ras mutations as pathogenetic and diagnostic markers in pancreatic cancer
    Mannhalter C.
    Koizar D.
    Chott A.
    Mitterbauer G.
    Udvardi G.
    Acta chirurgica Austriaca, 1998, 30 (3) : 196 - 197
  • [13] K-Ras and CDKN2a Mutations in Pancreatic Cancer
    Rachakonda, S.
    Bauer, A.
    Canzian, F.
    Scarpa, A.
    Neoptolemos, J.
    Werner, J.
    Giese, N.
    Heller, A.
    Hoheisel, J.
    Kumar, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S166 - S166
  • [14] K-Ras mutations and benign pancreatic disease
    Löhr, M
    Maisonneuve, P
    Lowenfels, AB
    INTERNATIONAL JOURNAL OF PANCREATOLOGY, 2000, 27 (02) : 93 - 103
  • [15] K-ras mutations and the diagnosis of pancreatic carcinoma
    Robinson, RA
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 105 (03) : 257 - 259
  • [16] K-ras mutations and benign pancreatic disease
    Matthias Löhr
    Patrick Maisonneuve
    Albert B. Lowenfels
    International Journal of Gastrointestinal Cancer, 2000, 27 : 93 - 103
  • [17] K-ras mutations in canine pancreatic cancers
    Mayr, B
    Schaffner, G
    Reifinger, M
    VETERINARY RECORD, 2003, 153 (03) : 87 - +
  • [18] Diagnostic value of K-ras mutations in serum of pancreatic cancer patients
    Theodor, L
    Melzer, E
    Sologov, M
    Bar-Meir, S
    CIRCULATING NUCLEIC ACIDS IN PLASMA OR SERUM, 2000, 906 : 19 - 24
  • [19] Detection of K-ras mutations in the plasma DNA of pancreatic cancer patients
    Uemura, T
    Hibi, K
    Kaneko, T
    Takeda, S
    Inoue, S
    Okochi, O
    Nagasaka, T
    Nakao, A
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (01) : 56 - 60
  • [20] A prospective study of K-ras mutations in the plasma of pancreatic cancer patients
    Mulcahy, HE
    Lyautey, J
    Lederrey, C
    Chen, XQ
    Anker, P
    Alstead, EM
    Ballinger, A
    Farthing, MJG
    Stroun, M
    CLINICAL CANCER RESEARCH, 1998, 4 (02) : 271 - 275